{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dysmenorrhoea/goals-outcome-measures/qipp-options-for-local-implementation/","result":{"pageContext":{"chapter":{"id":"99ca2fb4-b9f3-55f3-b3fc-2cb3a6140ca3","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation","depth":2,"htmlHeader":"<!-- begin field e8e4daca-1c2b-41a5-961d-b8212bf58498 --><h2>QIPP - Options for local implementation</h2><!-- end field e8e4daca-1c2b-41a5-961d-b8212bf58498 -->","summary":null,"htmlStringContent":"<!-- begin item 3c6f4899-329b-4caa-af7b-e6338160e89b --><!-- begin field 392a6826-b37c-49a0-9f63-812cb0d5a58a --><ul><li><strong>Non-steroidal anti-inflammatory drugs (NSAIDs)</strong><ul><li>Review the appropriateness of NSAID prescribing widely and on a routine basis, especially in people who are at higher risk of both gastrointestinal (GI) and cardiovascular (CV) morbidity and mortality (for example, older patients).</li><li>If an NSAID is needed, use ibuprofen (1,200 mg a day or less) or naproxen (1,000 mg a day or less). Use the lowest effective dose and the shortest duration of treatment necessary to control symptoms.</li><li>Co-prescribe a proton pump inhibitor (PPI) with NSAIDs for people with osteoarthritis, rheumatoid arthritis,Â and think about the use of gastroprotective treatment when prescribing NSAIDs for low back pain, axial spondyloarthritis, psoriatic arthritis and other peripheral spondyloarthritides.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dysmenorrhoea/references/\">NICE, 2018</a>]</p><!-- end field 392a6826-b37c-49a0-9f63-812cb0d5a58a --><!-- end item 3c6f4899-329b-4caa-af7b-e6338160e89b -->","topic":{"id":"0c7e1674-25ac-5412-81b0-d4d1ca0a6532","topicId":"d2202fa1-429e-4011-8135-3a2049c1d520","topicName":"Dysmenorrhoea","slug":"dysmenorrhoea","lastRevised":"Last revised in November 2018","chapters":[{"id":"f2974ab7-c383-5709-9194-8c1347a6e48d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"44579560-9fd2-537d-9b92-1eabb7a6143a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"663ab4e7-a158-568e-aec2-f7126771c014","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"4df0c333-cd3d-5a3c-afe4-0ae5fc002512","slug":"changes","fullItemName":"Changes"},{"id":"0cf82f0d-38d8-5014-b235-85ebadfd605b","slug":"update","fullItemName":"Update"}]},{"id":"0dbf2666-492f-549f-b313-71b596cc0bcb","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"658bff21-3654-5661-a3d2-b5876b69d66d","slug":"goals","fullItemName":"Goals"},{"id":"0462643f-eace-5cb8-bd65-a2ad2a6bc503","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f79c04ce-6e9e-530e-abe1-732f51abe4f9","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"966786c7-9c68-51d3-a65e-f510e133e935","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"99ca2fb4-b9f3-55f3-b3fc-2cb3a6140ca3","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"6f279400-7735-5332-860b-65383f816269","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"1240ce42-fa9b-587f-a779-df6cfaa6437e","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"470bee4d-280f-5695-9518-a1cef26ab7db","slug":"definition","fullItemName":"Definition"},{"id":"41df263c-252d-5f94-a7e5-7075a706ca73","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9064c3fa-918a-59ee-82c8-1b64076bea3a","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"111560c2-8bc9-57c8-83a3-14a4bc9cb537","slug":"impact","fullItemName":"Impact"}]},{"id":"31c4642b-d290-511c-876a-b3c9bf5c05e8","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"9e57c91b-71e7-5b04-8caf-81fe28fb3138","slug":"assessment","fullItemName":"Assessment"}]},{"id":"082477b9-8adf-57e4-91b7-7aba32969c6f","fullItemName":"Management","slug":"management","subChapters":[{"id":"27fbeb95-a0df-5d64-8bd8-27370c30f372","slug":"primary-dysmenorrhoea","fullItemName":"Scenario: Primary dysmenorrhoea"},{"id":"43361bbb-ae8f-5ca6-8454-2e8e5549c99f","slug":"secondary-dysmenorrhoea","fullItemName":"Scenario: Secondary dysmenorrhoea"}]},{"id":"671cbd64-2abc-53b7-8042-656007db062e","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"d51cf8f7-55d4-59bd-a4f8-37d09e71d89f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"acb9d93f-df11-56e0-aa31-f4174fae9d24","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c7e3ba8a-24a7-5158-9416-9c5f71bdd035","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"95e6d539-0c3a-5a89-a916-8b5b5a90ff4c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9e6affac-20d1-5beb-9283-787dccb74b65","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"188722b3-3b43-511c-a127-6e20de2faca2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c3438447-13a8-5fc3-8f6e-692e576f9959","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"0dbf2666-492f-549f-b313-71b596cc0bcb","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}